G. Kurtz

Neurochemical and neuroendocrine measures and prediction of outcome to neuroleptic therapy

C. Hock, F. Müller-Spahn, G. Kurtz, 1994 .

Brain dysfunction during motor activation and corpus callosum alterations in Schizophrenia measured by cerebral blood flow and magnetic resonance imaging

Reinhard Steinberg, W. Günther, H. Hippius, 1991, Biological Psychiatry.

Definition, Diagnostik und Therapie schizophrener Minussymptomatik

C. Hock, F. Müller-Spahn, G. Kurtz, 1995 .

Elevated response of growth hormone to graded doses of apomorphine in schizophrenic patients.

A. Brachner, M. Ackenheil, F. Müller-Spahn, 1998, Journal of psychiatric research.

Secondary psychotic symptoms in a patient with biphasic meningo-encephalitis

F. Müller-Spahn, G. Kurtz, S. Modell, 1993, European Psychiatry.

Zotepine: its clinical efficacy considered in relation to its effect on neurotransmitter-receptor systems

B. Bondy, M. Ackenheil, F. Müller-Spahn, 1991, European Neuropsychopharmacology.

Normal P300 in acute schizophrenics during a continuous performance test

R. Engel, M. Wagner, G. Kurtz, 1989, Biological Psychiatry.